- Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
- Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
- Best practices for tissue and liquid biopsy selection, handling, and quality assurance, including considerations for ctDNA and MRD testing.
- Case-based examples demonstrating optimal specimens for clinical trial enrollment, as well as common pitfalls in tissue and ctDNA/MRD workflows leading to case failures.
- How Natera harnesses real-world data from its commercial pipeline to accelerate clinical trial advancement and enrollment
Archives: Agenda
Planning and executing patient-centric clinical studies: Lessons learned from the WISDOM Study platform for personalized breast cancer screening
- Incorporating patient-centric strategies in trial designs to reduce patient burden
- Overview of new innovations that can be included in studies to increase patient centricity
- Adopting a patient-first mindset when designing trial protocols for patient-friendly studies
The real reason trials fail isn’t recruitment… it’s design
- Why most oncology trial delays are designed in before the first patient is enrolled
- How Pharma, Biotech and CRO teams are using AI to eliminate amendments before they happen
- What it takes to build a protocol that actually works operationally, globally, and regulator-ready from day one
Oncology trials as a start-up: Identifying challenges and pain points to overcome and conduct effective oncology clinical trials
- Understanding the unique challenges biotechs face to reduce roadblocks and ensure clinical trial success
- Weighing up in-house capacity versus budget to ensure effective outsourcing decisions
- Working with limited resources to ensure regulatory compliance and minimize roadblocks
Planning ahead to mitigate risk and stick to tight timelines
- Simplifying trial design and procedures to reduce operational complexity
- Implementing RBQM strategies to identify and mitigate roadblocks to reduce delays
PRIZE DRAW
Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon giftcards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!
Registration and refreshments
Chairperson’s opening remarks
Interactive Speaker-Hosted Roundtable Discussions
Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within oncology clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.
| Roundtable 1 | Balancing quality, speed and cost in complex oncology trials
Umar Hayat Ph.D., Founder, CEO, Accanito Therapeutics Inc |
| Roundtable 2 | Is AI overhyped? Understanding how to incorporate AI to enhance trial processes
Radha Duttagupta, Vice President, Clinical Affairs, Nucleix |
| Roundtable 3 | Leveraging strong academic networks for complex oncology trials to assist in research and drug development
Irene Acerbi Soto, Clinical Implementations & Operations Manager, University of California San Francisco |
| Roundtable 4 | Tissue is the Issue: How to overcome limited oncologic samples to achieve clinical trial success
Osama Khan MD, FCAP, FRCPC, Anatomical Pathologist, Oncology, Natera |